Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 195 entries
Sorted by: Best Match Show Resources per page
A 2D flow visualization user study using explicit flow synthesis and implicit task design.

IEEE transactions on visualization and computer graphics

Liu Z, Cai S, Swan JE, Moorhead RJ, Martin JP, Jankun-Kelly TJ.
PMID: 21690646
IEEE Trans Vis Comput Graph. 2012 May;18(5):783-96. doi: 10.1109/TVCG.2011.110.

This paper presents a 2D flow visualization user study that we conducted using new methodologies to increase the objectiveness. We evaluated grid-based variable-size arrows, evenly spaced streamlines, and line integral convolution (LIC) variants (basic, oriented, and enhanced versions) coupled...

Cite
Liu Z, Cai S, Swan JE, et al. A 2D flow visualization user study using explicit flow synthesis and implicit task design. IEEE Trans Vis Comput Graph. 2012;18(5):783-96doi: 10.1109/TVCG.2011.110.
Liu, Z., Cai, S., Swan, J. E., Moorhead, R. J., Martin, J. P., & Jankun-Kelly, T. J. (2012). A 2D flow visualization user study using explicit flow synthesis and implicit task design. IEEE transactions on visualization and computer graphics, 18(5), 783-96. https://doi.org/10.1109/TVCG.2011.110
Liu, Zhanping, et al. "A 2D flow visualization user study using explicit flow synthesis and implicit task design." IEEE transactions on visualization and computer graphics vol. 18,5 (2012): 783-96. doi: https://doi.org/10.1109/TVCG.2011.110
Liu Z, Cai S, Swan JE, Moorhead RJ, Martin JP, Jankun-Kelly TJ. A 2D flow visualization user study using explicit flow synthesis and implicit task design. IEEE Trans Vis Comput Graph. 2012 May;18(5):783-96. doi: 10.1109/TVCG.2011.110. PMID: 21690646.
Copy Download .nbib Format: NLM
ROR2 Promoter Methylation Change in Osteoblastic Differentiation of Mesenchymal Stem Cells.

Cell journal

Tarfiei G, Noruzinia M, Soleimani M, Kaviani S, Mahmoodinia Maymand M, Farshdousti Hagh M, Pujol P.
PMID: 23671822
Cell J. 2011;13(1):11-5. Epub 2011 Apr 21.

OBJECTIVE: Osteoblasts arise from multipotent mesenchymal stem cells (MSCs) present in the bone marrow stroma and undergo further differentiation to osteocytes or bone cells. Many factors such as proteins present in the Wnt signaling pathway affect osteoblast differentiation. ROR2...

Cite
Tarfiei G, Noruzinia M, Soleimani M, et al. ROR2 Promoter Methylation Change in Osteoblastic Differentiation of Mesenchymal Stem Cells. Cell J. 2011;13(1):11-5
Tarfiei, G., Noruzinia, M., Soleimani, M., Kaviani, S., Mahmoodinia Maymand, M., Farshdousti Hagh, M., & Pujol, P. (2011). ROR2 Promoter Methylation Change in Osteoblastic Differentiation of Mesenchymal Stem Cells. Cell journal, 13(1), 11-5.
Tarfiei, Gorbanali, et al. "ROR2 Promoter Methylation Change in Osteoblastic Differentiation of Mesenchymal Stem Cells." Cell journal vol. 13,1 (2011): 11-5.
Tarfiei G, Noruzinia M, Soleimani M, Kaviani S, Mahmoodinia Maymand M, Farshdousti Hagh M, Pujol P. ROR2 Promoter Methylation Change in Osteoblastic Differentiation of Mesenchymal Stem Cells. Cell J. 2011;13(1):11-5. Epub 2011 Apr 21. PMID: 23671822; PMCID: PMC3652535.
Copy Download .nbib Format: NLM
Giving credit where credit is due?.

American journal of obstetrics and gynecology

Hummel P.
PMID: 22748481
Am J Obstet Gynecol. 2012 Oct;207(4):e9. doi: 10.1016/j.ajog.2012.06.017. Epub 2012 Jun 14.

No abstract available.

Cite
Hummel P. Giving credit where credit is due?. Am J Obstet Gynecol. 2012;207(4):e9doi: 10.1016/j.ajog.2012.06.017.
Hummel, P. (2012). Giving credit where credit is due?. American journal of obstetrics and gynecology, 207(4), e9. https://doi.org/10.1016/j.ajog.2012.06.017
Hummel, Pieter. "Giving credit where credit is due?." American journal of obstetrics and gynecology vol. 207,4 (2012): e9. doi: https://doi.org/10.1016/j.ajog.2012.06.017
Hummel P. Giving credit where credit is due?. Am J Obstet Gynecol. 2012 Oct;207(4):e9. doi: 10.1016/j.ajog.2012.06.017. Epub 2012 Jun 14. PMID: 22748481.
Copy Download .nbib Format: NLM
Letter to the Editor: (1)H, (15)N and (13)C assignments of FLIN4, an intramolecular LMO4:ldb1 complex.

Journal of biomolecular NMR

Deane JE, Visvader JE, Mackay JP, Matthews JM.
PMID: 20859789
J Biomol NMR. 2002 Jun;23(2):165-6. doi: 10.1023/A:1016363414644.

No abstract available.

Cite
Deane JE, Visvader JE, Mackay JP, et al. Letter to the Editor: (1)H, (15)N and (13)C assignments of FLIN4, an intramolecular LMO4:ldb1 complex. J Biomol NMR. 2002;23(2):165-6doi: 10.1023/A:1016363414644.
Deane, J. E., Visvader, J. E., Mackay, J. P., & Matthews, J. M. (2002). Letter to the Editor: (1)H, (15)N and (13)C assignments of FLIN4, an intramolecular LMO4:ldb1 complex. Journal of biomolecular NMR, 23(2), 165-6. https://doi.org/10.1023/A:1016363414644
Deane, Janet E, et al. "Letter to the Editor: (1)H, (15)N and (13)C assignments of FLIN4, an intramolecular LMO4:ldb1 complex." Journal of biomolecular NMR vol. 23,2 (2002): 165-6. doi: https://doi.org/10.1023/A:1016363414644
Deane JE, Visvader JE, Mackay JP, Matthews JM. Letter to the Editor: (1)H, (15)N and (13)C assignments of FLIN4, an intramolecular LMO4:ldb1 complex. J Biomol NMR. 2002 Jun;23(2):165-6. doi: 10.1023/A:1016363414644. PMID: 20859789.
Copy Download .nbib Format: NLM
Statistical transmutation in doped quantum dimer models.

Physical review letters

Lamas CA, Ralko A, Cabra DC, Poilblanc D, Pujol P.
PMID: 23031119
Phys Rev Lett. 2012 Jul 06;109(1):016403. doi: 10.1103/PhysRevLett.109.016403. Epub 2012 Jul 03.

We prove a "statistical transmutation" symmetry of doped quantum dimer models on the square, triangular, and kagome lattices: the energy spectrum is invariant under a simultaneous change of statistics (i.e., bosonic into fermionic or vice versa) of the holes...

Cite
Lamas CA, Ralko A, Cabra DC, et al. Statistical transmutation in doped quantum dimer models. Phys Rev Lett. 2012;109(1):016403doi: 10.1103/PhysRevLett.109.016403.
Lamas, C. A., Ralko, A., Cabra, D. C., Poilblanc, D., & Pujol, P. (2012). Statistical transmutation in doped quantum dimer models. Physical review letters, 109(1), 016403. https://doi.org/10.1103/PhysRevLett.109.016403
Lamas, C A, et al. "Statistical transmutation in doped quantum dimer models." Physical review letters vol. 109,1 (2012): 016403. doi: https://doi.org/10.1103/PhysRevLett.109.016403
Lamas CA, Ralko A, Cabra DC, Poilblanc D, Pujol P. Statistical transmutation in doped quantum dimer models. Phys Rev Lett. 2012 Jul 06;109(1):016403. doi: 10.1103/PhysRevLett.109.016403. Epub 2012 Jul 03. PMID: 23031119.
Copy Download .nbib Format: NLM
Epstein-Barr Virus-Positive Mucocutaneous Ulcer in an Immunosuppressed Patient.

ACG case reports journal

Hujoel IA, Rubio-Tapia A, Dao LN, Porrata LF, Kane SV.
PMID: 29721514
ACG Case Rep J. 2018 Apr 25;5:e32. doi: 10.14309/crj.2018.32. eCollection 2018.

Immunosuppressive medications, frequently used to treat inflammatory bowel disease, have been linked to the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disorders (LPD). We describe a case of an EBV-positive mucocutaneous ulcer involving the palate in an elderly woman with...

Cite
Hujoel IA, Rubio-Tapia A, Dao LN, et al. Epstein-Barr Virus-Positive Mucocutaneous Ulcer in an Immunosuppressed Patient. ACG Case Rep J. 2018;5:e32doi: 10.14309/crj.2018.32.
Hujoel, I. A., Rubio-Tapia, A., Dao, L. N., Porrata, L. F., & Kane, S. V. (2018). Epstein-Barr Virus-Positive Mucocutaneous Ulcer in an Immunosuppressed Patient. ACG case reports journal, 5e32. https://doi.org/10.14309/crj.2018.32
Hujoel, Isabel A, et al. "Epstein-Barr Virus-Positive Mucocutaneous Ulcer in an Immunosuppressed Patient." ACG case reports journal vol. 5 (2018): e32. doi: https://doi.org/10.14309/crj.2018.32
Hujoel IA, Rubio-Tapia A, Dao LN, Porrata LF, Kane SV. Epstein-Barr Virus-Positive Mucocutaneous Ulcer in an Immunosuppressed Patient. ACG Case Rep J. 2018 Apr 25;5:e32. doi: 10.14309/crj.2018.32. eCollection 2018. PMID: 29721514; PMCID: PMC5917941.
Copy Download .nbib Format: NLM
Endovascular repair of an innominate artery pseudoaneurysm using the Valiant Mona LSA branched graft device.

Journal of vascular surgery cases and innovative techniques

Sibille JA, Harding JP, Ballast JK, Hooshmand M, Madjarov JM, Arko FR.
PMID: 29349361
J Vasc Surg Cases Innov Tech. 2016 Dec 24;3(1):1-3. doi: 10.1016/j.jvscit.2016.09.009. eCollection 2017 Mar.

A 60-year-old woman involved in a motor vehicle collision presented with a traumatic pseudoaneurysm of the innominate artery origin in addition to multiple concomitant injuries. She was classified as a high-risk candidate for open repair. An experimental thoracic branched...

Cite
Sibille JA, Harding JP, Ballast JK, et al. Endovascular repair of an innominate artery pseudoaneurysm using the Valiant Mona LSA branched graft device. J Vasc Surg Cases Innov Tech. 2016;3(1):1-3doi: 10.1016/j.jvscit.2016.09.009.
Sibille, J. A., Harding, J. P., Ballast, J. K., Hooshmand, M., Madjarov, J. M., & Arko, F. R. (2017). Endovascular repair of an innominate artery pseudoaneurysm using the Valiant Mona LSA branched graft device. Journal of vascular surgery cases and innovative techniques, 3(1), 1-3. https://doi.org/10.1016/j.jvscit.2016.09.009
Sibille, Josh A, et al. "Endovascular repair of an innominate artery pseudoaneurysm using the Valiant Mona LSA branched graft device." Journal of vascular surgery cases and innovative techniques vol. 3,1 (2017): 1-3. doi: https://doi.org/10.1016/j.jvscit.2016.09.009
Sibille JA, Harding JP, Ballast JK, Hooshmand M, Madjarov JM, Arko FR. Endovascular repair of an innominate artery pseudoaneurysm using the Valiant Mona LSA branched graft device. J Vasc Surg Cases Innov Tech. 2016 Dec 24;3(1):1-3. doi: 10.1016/j.jvscit.2016.09.009. eCollection 2017 Mar. PMID: 29349361; PMCID: PMC5757800.
Copy Download .nbib Format: NLM
Patent Foramen Ovale Closure in 2019.

Interventional cardiology (London, England)

Giblett JP, Abdul-Samad O, Shapiro LM, Rana BS, Calvert PA.
PMID: 30858890
Interv Cardiol. 2019 Feb;14(1):34-41. doi: 10.15420/icr.2018.33.2.

Patent foramen ovale (PFO) is a common abnormality affecting between 20% and 34% of the adult population. For most people it is a benign finding; however, in some the PFO can open widely, enabling a paradoxical embolus to transit...

Cite
Giblett JP, Abdul-Samad O, Shapiro LM, et al. Patent Foramen Ovale Closure in 2019. Interv Cardiol. 2019;14(1):34-41doi: 10.15420/icr.2018.33.2.
Giblett, J. P., Abdul-Samad, O., Shapiro, L. M., Rana, B. S., & Calvert, P. A. (2019). Patent Foramen Ovale Closure in 2019. Interventional cardiology (London, England), 14(1), 34-41. https://doi.org/10.15420/icr.2018.33.2
Giblett, Joel P, et al. "Patent Foramen Ovale Closure in 2019." Interventional cardiology (London, England) vol. 14,1 (2019): 34-41. doi: https://doi.org/10.15420/icr.2018.33.2
Giblett JP, Abdul-Samad O, Shapiro LM, Rana BS, Calvert PA. Patent Foramen Ovale Closure in 2019. Interv Cardiol. 2019 Feb;14(1):34-41. doi: 10.15420/icr.2018.33.2. PMID: 30858890; PMCID: PMC6406129.
Copy Download .nbib Format: NLM
Intracellular Delivery of Gold Nanocolloids Promoted by a Chemically Conjugated Anticancer Peptide.

ACS omega

Kapur A, Medina SH, Wang W, Palui G, Schneider JP, Mattoussi H.
PMID: 30411018
ACS Omega. 2018 Oct 31;3(10):12754-12762. doi: 10.1021/acsomega.8b02276. Epub 2018 Oct 08.

We report on the ability of a chemically synthesized anticancer peptide, SVS-1, to promote the rapid uptake of gold nanorods (AuNRs) and gold nanoparticles (AuNPs) by live HeLa cells. For this, AuNPs and AuNRs, surface ligated with a multicoordinating...

Cite
Kapur A, Medina SH, Wang W, et al. Intracellular Delivery of Gold Nanocolloids Promoted by a Chemically Conjugated Anticancer Peptide. ACS Omega. 2018;3(10):12754-12762doi: 10.1021/acsomega.8b02276.
Kapur, A., Medina, S. H., Wang, W., Palui, G., Schneider, J. P., & Mattoussi, H. (2018). Intracellular Delivery of Gold Nanocolloids Promoted by a Chemically Conjugated Anticancer Peptide. ACS omega, 3(10), 12754-12762. https://doi.org/10.1021/acsomega.8b02276
Kapur, Anshika, et al. "Intracellular Delivery of Gold Nanocolloids Promoted by a Chemically Conjugated Anticancer Peptide." ACS omega vol. 3,10 (2018): 12754-12762. doi: https://doi.org/10.1021/acsomega.8b02276
Kapur A, Medina SH, Wang W, Palui G, Schneider JP, Mattoussi H. Intracellular Delivery of Gold Nanocolloids Promoted by a Chemically Conjugated Anticancer Peptide. ACS Omega. 2018 Oct 31;3(10):12754-12762. doi: 10.1021/acsomega.8b02276. Epub 2018 Oct 08. PMID: 30411018; PMCID: PMC6210078.
Copy Download .nbib Format: NLM
Drug-Target Interaction Prediction: End-to-End Deep Learning Approach.

IEEE/ACM transactions on computational biology and bioinformatics

Monteiro NRC, Ribeiro B, Arrais JP.
PMID: 32142454
IEEE/ACM Trans Comput Biol Bioinform. 2021 Nov-Dec;18(6):2364-2374. doi: 10.1109/TCBB.2020.2977335. Epub 2021 Dec 08.

The discovery of potential Drug-Target Interactions (DTIs) is a determining step in the drug discovery and repositioning process, as the effectiveness of the currently available antibiotic treatment is declining. Although putting efforts on the traditional in vivo or in...

Cite
Monteiro NRC, Ribeiro B, Arrais JP. Drug-Target Interaction Prediction: End-to-End Deep Learning Approach. IEEE/ACM Trans Comput Biol Bioinform. 2021;18(6):2364-2374doi: 10.1109/TCBB.2020.2977335.
Monteiro, N. R. C., Ribeiro, B., & Arrais, J. P. (2021). Drug-Target Interaction Prediction: End-to-End Deep Learning Approach. IEEE/ACM transactions on computational biology and bioinformatics, 18(6), 2364-2374. https://doi.org/10.1109/TCBB.2020.2977335
Monteiro, Nelson R C, et al. "Drug-Target Interaction Prediction: End-to-End Deep Learning Approach." IEEE/ACM transactions on computational biology and bioinformatics vol. 18,6 (2021): 2364-2374. doi: https://doi.org/10.1109/TCBB.2020.2977335
Monteiro NRC, Ribeiro B, Arrais JP. Drug-Target Interaction Prediction: End-to-End Deep Learning Approach. IEEE/ACM Trans Comput Biol Bioinform. 2021 Nov-Dec;18(6):2364-2374. doi: 10.1109/TCBB.2020.2977335. Epub 2021 Dec 08. PMID: 32142454.
Copy Download .nbib Format: NLM
Two-dimensional materials for electrochemical CO.

Nanoscale

Chen Z, Wang X, Mills JP, Du C, Kim J, Wen J, Wu YA.
PMID: 34817491
Nanoscale. 2021 Nov 24; doi: 10.1039/d1nr06196h. Epub 2021 Nov 24.

Electrochemical CO

Cite
Chen Z, Wang X, Mills JP, et al. Two-dimensional materials for electrochemical CO. Nanoscale. 2021;doi: 10.1039/d1nr06196h.
Chen, Z., Wang, X., Mills, J. P., Du, C., Kim, J., Wen, J., & Wu, Y. A. (2021). Two-dimensional materials for electrochemical CO. Nanoscale, . https://doi.org/10.1039/d1nr06196h
Chen, Zuolong, et al. "Two-dimensional materials for electrochemical CO." Nanoscale vol. (2021). doi: https://doi.org/10.1039/d1nr06196h
Chen Z, Wang X, Mills JP, Du C, Kim J, Wen J, Wu YA. Two-dimensional materials for electrochemical CO. Nanoscale. 2021 Nov 24; doi: 10.1039/d1nr06196h. Epub 2021 Nov 24. PMID: 34817491.
Copy Download .nbib Format: NLM
Uncontrolled Epstein-Barr Virus as an Atypical Presentation of Deficiency in ADA2 (DADA2).

Journal of clinical immunology

Brooks JP, Rice AJ, Ji W, Lanahan SM, Konstantino M, Dara J, Hershfield MS, Cruickshank A, Dokmeci E, Lakhani S, Lucas CL.
PMID: 33394316
J Clin Immunol. 2021 Apr;41(3):680-683. doi: 10.1007/s10875-020-00940-1. Epub 2021 Jan 04.

No abstract available.

Cite
Brooks JP, Rice AJ, Ji W, et al. Uncontrolled Epstein-Barr Virus as an Atypical Presentation of Deficiency in ADA2 (DADA2). J Clin Immunol. 2021;41(3):680-683doi: 10.1007/s10875-020-00940-1.
Brooks, J. P., Rice, A. J., Ji, W., Lanahan, S. M., Konstantino, M., Dara, J., Hershfield, M. S., Cruickshank, A., Dokmeci, E., Lakhani, S., & Lucas, C. L. (2021). Uncontrolled Epstein-Barr Virus as an Atypical Presentation of Deficiency in ADA2 (DADA2). Journal of clinical immunology, 41(3), 680-683. https://doi.org/10.1007/s10875-020-00940-1
Brooks, Joel P, et al. "Uncontrolled Epstein-Barr Virus as an Atypical Presentation of Deficiency in ADA2 (DADA2)." Journal of clinical immunology vol. 41,3 (2021): 680-683. doi: https://doi.org/10.1007/s10875-020-00940-1
Brooks JP, Rice AJ, Ji W, Lanahan SM, Konstantino M, Dara J, Hershfield MS, Cruickshank A, Dokmeci E, Lakhani S, Lucas CL. Uncontrolled Epstein-Barr Virus as an Atypical Presentation of Deficiency in ADA2 (DADA2). J Clin Immunol. 2021 Apr;41(3):680-683. doi: 10.1007/s10875-020-00940-1. Epub 2021 Jan 04. PMID: 33394316.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 195 entries